{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:57:13Z","timestamp":1787169433239,"version":"build-2736575974"},"reference-count":34,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Depressive disorders are a leading cause of disability among women worldwide, yet existing interventions often fail to account for the biological and sociocultural factors shaping women\u2019s risk and symptom presentation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>In response, this randomized, single-blind, controlled trial will evaluate the efficacy of the 3D Program\u2014a gender-sensitive, guided internet-based cognitive behavioral therapy (iCBT) intervention for women with moderate depressive symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 120 women presenting with moderate depressive symptoms (17-item Hamilton Depression Rating Scale score 17\u201023), aged 18 to 45 years, will be randomized to receive either the 10-week 3D Program or informational video content, with both groups continuing treatment as usual. The 3D Program will integrate personalized therapist support, self-guided digital modules, and a moderated online group, with content cocreated alongside women with lived experience of depressive symptoms. The primary outcome will be the change in depressive symptom severity, measured by the 17-item Hamilton Depression Rating Scale at 12- and 26-week postbaseline assessments. Secondary outcomes will include functioning, quality of life, perceived stress, and menstrual-related distress. Additionally, the study will explore potential biological predictors of treatment response, analyzing metabolic markers related to tryptophan metabolism and adrenal steroid pathways across multiple biological matrices. Data analyses will use linear mixed-effects models and multivariate techniques to examine treatment effects and possible biomarker associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The trial was funded in October 2023 (grant PI23\/00257, Spanish Ministry of Economy and Competitiveness), and ethical approval was obtained in February 2024. The trial was registered in July 2025 (ClinicalTrials.gov NCT07060690). Data collection began in March 2026 and is projected to conclude in August 2027. As of April 2026, a total of 8 participants have been enrolled. Data analysis has not yet commenced. The results are expected to be published in the summer of 2028.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This trial aims to address critical gaps in accessible, personalized, and gender-sensitive mental health care. If effective, the 3D Program may serve as a scalable, cost-efficient adjunct to routine care for women with depressive symptoms in public health systems, while biomarker findings may lay the groundwork for future trials examining predictors of response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/99700","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:01:20Z","timestamp":1787166080000},"page":"e99700-e99700","source":"Crossref","is-referenced-by-count":0,"title":["A Women-Centered Internet-Based Cognitive Behavioral Therapy for Depressive Symptoms (the 3D Program): Protocol for a Randomized Controlled Trial"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8925-2754","authenticated-orcid":false,"given":"Natalia","family":"Angarita-Osorio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8529-544X","authenticated-orcid":false,"given":"Aitana","family":"Garc\u00eda-Estela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0930-2961","authenticated-orcid":false,"given":"Livia A","family":"Terraneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7684-1541","authenticated-orcid":false,"given":"Nathaly","family":"Nu\u00f1ez Pazmi\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0604-770X","authenticated-orcid":false,"given":"Noem\u00ed","family":"Haro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1735-9728","authenticated-orcid":false,"given":"Oscar J","family":"Pozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9516-9030","authenticated-orcid":false,"given":"Francesc","family":"Colom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1155\/da\/5553491","article-title":"Trends in prevalent cases and disability-adjusted life-years of depressive disorders worldwide: findings from the Global Burden of Disease Study from 1990 to 2021","volume":"2025","author":"Chen","journal-title":"Depress Anxiety"},{"issue":"5","key":"R2","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1016\/S2468-2667(24)00053-7","article-title":"Differences across the lifespan between females and males in the top 20 causes of disease burden globally: a systematic analysis of the Global Burden of Disease Study 2021","volume":"9","author":"Patwardhan","journal-title":"Lancet Public Health"},{"key":"R3","unstructured":"Prevalence of active depressive episodes by sex and age group. Population aged 15 years and over [Article in Spanish]. Instituto Nacional de Estad\u00edstica (INE). 2021. URL: https:\/\/www.ine.es\/jaxi\/Datos.htm?path=\/t15\/p420\/a2019\/p01\/l0\/&file=13007.px#_tabs-grafico [Accessed 18-07-2026]"},{"issue":"6","key":"R4","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1192\/bjp.177.6.486","article-title":"Gender differences in depression","volume":"177","author":"Piccinelli","journal-title":"Br J Psychiatry"},{"issue":"6","key":"R5","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1177\/0020764016653980","article-title":"Symptom endorsement in men versus women with a diagnosis of depression: a differential item functioning approach","volume":"62","author":"Cavanagh","journal-title":"Int J Soc Psychiatry"},{"issue":"2","key":"R6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S2215-0366(16)30263-2","article-title":"Why is depression more common among women than among men?","volume":"4","author":"Kuehner","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"R7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000531588","article-title":"Depression in women: potential biological and sociocultural factors driving the sex effect","volume":"83","author":"Di Benedetto","journal-title":"Neuropsychobiology"},{"issue":"12","key":"R8","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/S2215-0366(24)00317-1","article-title":"Service coverage for major depressive disorder: estimated rates of minimally adequate treatment for 204 countries and territories in 2021","volume":"11","author":"Santomauro","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"R9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003901","article-title":"The global gap in treatment coverage for major depressive disorder in 84 countries from 2000-2019: a systematic review and Bayesian meta-regression analysis","volume":"19","author":"Moitra","journal-title":"PLoS Med"},{"issue":"10328","key":"R10","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)02141-3","article-title":"Time for united action on depression: a Lancet\u2013world Psychiatric Association Commission","volume":"399","author":"Herrman","journal-title":"The Lancet"},{"issue":"2","key":"R11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/wps.20860","article-title":"Psychotherapies for depression: a network meta-analysis covering efficacy, acceptability and long-term outcomes of all main treatment types","volume":"20","author":"Cuijpers","journal-title":"World Psychiatry"},{"key":"R12","unstructured":"Revisi\u00f3n de la gu\u00eda de pr\u00e1ctica cl\u00ednica sobre el manejo de la depresi\u00f3n en el adulto (2014) del programa de GPC en el SNS [Report in Spanish]. Ministerio de Sanidad; 2014. URL: https:\/\/cpage.mpr.gob.es\/publicacion\/revision-de-la-guia-de-practica-clinica-sobre-el-manejo-de-la-depresion-en-el-adulto-2014-del-programa-de-gpc-en-el-sns-2023-133230738-0000\/ [Accessed 18-07-2026]"},{"issue":"3","key":"R13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S2215-0366(24)00404-8","article-title":"Efficacy and effectiveness of therapist-guided internet versus face-to-face cognitive behavioural therapy for depression via counterfactual inference using naturalistic registers and machine learning in Finland: a retrospective cohort study","volume":"12","author":"Rosenstr\u00f6m","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"R14","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/s10608-018-9979-5","article-title":"Predictors of dropout in internet-based cognitive behavioral therapy for depression","volume":"43","author":"Schmidt","journal-title":"Cognit Ther Res"},{"issue":"8","key":"R15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1037\/bul0000334","article-title":"Digital interventions for the treatment of depression: a meta-analytic review","volume":"147","author":"Moshe","journal-title":"Psychol Bull"},{"issue":"4","key":"R16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1177\/1099800418776082","article-title":"Biological sex differences in depression: a systematic review","volume":"20","author":"Labaka","journal-title":"Biol Res Nurs"},{"issue":"2","key":"R17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.physbeh.2009.02.033","article-title":"Sex differences in psychopathology: of gonads, adrenals and mental illness","volume":"97","author":"Solomon","journal-title":"Physiol Behav"},{"issue":"8","key":"R18","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1038\/s41380-020-00951-9","article-title":"The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies","volume":"26","author":"Marx","journal-title":"Mol Psychiatry"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00249","article-title":"Inflammation-induced tryptophan breakdown is related with anemia, fatigue, and depression in cancer","volume":"11","author":"Lanser","journal-title":"Front Immunol"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01332","article-title":"Glucocorticoids, sex hormones, and immunity","volume":"9","author":"Bereshchenko","journal-title":"Front Immunol"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081477","article-title":"SPIRIT 2025 statement: updated guideline for protocols of randomised trials","volume":"389","author":"Chan","journal-title":"BMJ"},{"key":"R22","unstructured":"Clinical Trial Randomization Tool. Division of Cancer Prevention, National Cancer Institute (NCI). URL: https:\/\/prevention.cancer.gov\/ctrandomization\/tool\/ [Accessed 16-02-2026]"},{"issue":"1","key":"R23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0022-3956(88)90024-6","article-title":"A new validation of the Hamilton Rating Scale for Depression","volume":"22","author":"Ramos-Brieva","journal-title":"J Psychiatr Res"},{"issue":"1","key":"R24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"R25","first-page":"77","volume":"28","author":"V\u00e1zquez-Barquero","journal-title":"Actas Esp Psiquiatr"},{"key":"R26","unstructured":"Ustun TB Kostanjesek N Chatterji S Rehm J . Measuring Health and Disability: Manual for WHO Disability Assessment Schedule (WHODAS 20). World Health Organization; 2010. ISBN: 978-92-4-154759-8"},{"issue":"9","key":"R27","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1007\/s11136-018-1877-5","article-title":"Validity of the EQ-5D-5L and reference norms for the Spanish population","volume":"27","author":"Hernandez","journal-title":"Qual Life Res"},{"issue":"3","key":"R28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol\u2014a new facility for the measurement of health-related quality of life","volume":"16","author":"EuroQol Group","journal-title":"Health Policy"},{"issue":"4","key":"R29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2307\/2136404","article-title":"A global measure of perceived stress","volume":"24","author":"Cohen","journal-title":"J Health Soc Behav"},{"issue":"1","key":"R30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1017\/s1138741600006004","article-title":"Psychometric properties of a European Spanish version of the Perceived Stress Scale (PSS)","volume":"9","author":"Remor","journal-title":"Span J Psychol"},{"issue":"6","key":"R31","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.rbmo.2021.08.029","article-title":"Menstrual Distress Questionnaire (MEDI-Q): a new tool to assess menstruation-related distress","volume":"43","author":"Vannuccini","journal-title":"Reprod Biomed Online"},{"key":"R32","unstructured":"ICH Harmonised Guideline: guideline for good clinical practice E6(R3). International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH); 2025. URL: https:\/\/database.ich.org\/sites\/default\/files\/ICH_E6%28R3%29_Step4_FinalGuideline_2025_0106.pdf [Accessed 10-04-2026]"},{"issue":"2","key":"R33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","journal-title":"J Biomed Inform"},{"issue":"6","key":"R34","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1038\/s41591-025-03635-5","article-title":"CONSORT 2025 statement: updated guideline for reporting randomized trials","volume":"31","author":"Hopewell","journal-title":"Nat Med"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:01:29Z","timestamp":1787166089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e99700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":34,"URL":"https:\/\/doi.org\/10.2196\/99700","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"article-number":"v15i5e99700"}}